Speciality Medicines Ltd. (SPML) Share Price Surges 9.97% Today

Speciality Medicines Ltd. Share Price surges 9.97% to Rs 198, clearing the Micro Cap threshold of 8.1%.

Speciality Medicines Ltd. Share Price has experienced a significant surge today, rising by 9.97% to reach Rs 198. This impressive gain comes as the company clears the Micro Cap category threshold of 8.1%, highlighting its strong performance in the market. With a market capitalisation of Rs 162.54 crore, Speciality Medicines Ltd. has captured the attention of investors and analysts alike.

The company’s share price opened at Rs 189.9 and reached a high of Rs 198, demonstrating robust upward momentum. The trading volume on the BSE was recorded at 6,000 shares, with a turnover of Rs 0.12 crore. This price action positions Speciality Medicines Ltd. as a top gainer in today’s market, drawing interest from market participants keen to understand the factors driving this rally.

Speciality Medicines Ltd. Share Price Today: Price Action Analysis

Metric	Value
Current Price	Rs 198
Previous Close	Rs 180.05
Today's Change	+Rs 17.95 (+9.97%)
Day Open	Rs 189.9
Day High	Rs 198
Day Low	Rs 189.9
Current Volume (BSE)	6,000
BSE Traded Volume	6,000
Combined NSE + BSE Volume	6,000
Turnover	Rs 0.12 crore
Market Capitalisation	Rs 162.54 crore
Market Cap Category	Micro Cap
Qualifying Threshold Cleared	8.1%

Today’s price action for Speciality Medicines Ltd. is noteworthy, with the share price climbing from a previous close of Rs 180.05 to a current price of Rs 198. This represents a day change of Rs 17.95, or a 9.97% increase, which is well above the qualifying threshold of 8.1% for the Micro Cap category. The stock opened at Rs 189.9, reached a high of Rs 198, and did not dip below its opening price, indicating strong buying interest throughout the trading session.

The total volume of 6,000 shares traded on the BSE suggests moderate participation, with a turnover of Rs 0.12 crore. This volume is consistent with the company’s market capitalisation of Rs 162.54 crore, reflecting investor confidence in the stock’s potential. The day’s trading activity positions Speciality Medicines Ltd. as a standout performer, with its share price gain attracting attention from both retail and institutional investors.

Speciality Medicines Ltd. Fundamental Analysis

Metric	Value
Market Capitalisation	Rs 162.54 crore
P/E Ratio	12.14x
P/B Ratio	2.22x
ROE	76.56%
ROCE	69.75%
EPS	Rs 14.83
Book Value Per Share	Rs 81.03
Dividend Yield	0%

Speciality Medicines Ltd. was valued at a P/E ratio of 12.14x, a P/B ratio of 2.22x. These multiples provide valuation context, but they should not be labelled expensive or inexpensive without a comparable peer or sector benchmark.

Profitability and capital efficiency were represented by ROE of 76.56% and ROCE of 69.75%. ROE relates profit to shareholder equity, while ROCE measures returns generated on the capital employed in the business.

Per-share and shareholder-return metrics included EPS of Rs 14.83, book value per share of Rs 81.03, dividend yield of 0%. Dividend yield is a current or historical ratio and does not guarantee future distributions.

From a fundamental perspective, Speciality Medicines Ltd. presents a compelling case for investor interest. With a market capitalisation of Rs 162.54 crore, the company is positioned within the Micro Cap category, offering potential for growth and expansion. The price-to-earnings (P/E) ratio of 12.14 is below the industry median of 14.93, suggesting that the stock may be undervalued relative to its peers.

The company’s return on equity (ROE) is an impressive 76.56%, significantly higher than the industry median of 1.97%. This indicates efficient management and strong profitability, which are attractive qualities for investors. Additionally, the return on capital employed (ROCE) of 69.75% further underscores the company’s ability to generate returns on its investments.

Speciality Medicines Ltd. also boasts an earnings per share (EPS) of Rs 14.83 and a book value of Rs 81.03 per share. While the dividend yield is currently at 0%, the company’s strong ROE and ROCE metrics highlight its potential for future growth and value creation.

Sector and Industry Context

Metric	Value
Sector	Trading
Industry	Trading
Benchmark Scope	same industry
Companies in Benchmark	435
Company P/E Ratio	12.14x
Benchmark Median P/E	14.93x
Benchmark Average P/E	71.59x
Benchmark P/E Range	0x to 2,181.81x
Companies with P/E Data	435
Company P/B Ratio	2.22x
Benchmark Median P/B	1.31x
Company ROE	76.56%
Benchmark Median ROE	1.97%
Company ROCE	69.75%
Benchmark Median ROCE	3.89%
Company Market Capitalisation	Rs 162.54 crore
Benchmark Median Market Cap	Rs 46.07 crore

Speciality Medicines Ltd. (SPML) is classified under sector: Trading and industry: Trading. The numerical benchmark uses 435 same industry companies from the supplied master-data set.

Speciality Medicines Ltd. (SPML) has a P/E ratio of 12.14x, which is below the benchmark median of 14.93x, a difference of -18.69%. The benchmark contains 435 companies with P/E data, ranging from 0x to 2,181.81x. P/E is a valuation multiple and is not, by itself, a buy or sell signal.

Speciality Medicines Ltd. (SPML) has a ROE of 76.56%, which is above the benchmark median of 1.97%, a difference of +3,786.29%. Speciality Medicines Ltd. (SPML) has a ROCE of 69.75%, which is above the benchmark median of 3.89%, a difference of +1,693.06%.

Track today’s top gainers through the Univest top gainers screener. The peer table below provides the company-level comparison.

Speciality Medicines Ltd. operates within the Trading sector, which encompasses a wide range of companies involved in the buying and selling of goods and services. The sector’s benchmark includes 435 companies, providing a comprehensive overview of industry performance and trends.

Within this context, Speciality Medicines Ltd.’s P/E ratio of 12.14 is below the industry median of 14.93, indicating a potential undervaluation. The company’s P/B ratio of 2.22, however, is above the industry median of 1.31, suggesting a higher valuation in terms of book value.

The company’s ROE and ROCE are significantly higher than industry averages, with ROE at 76.56% compared to the industry median of 1.97%, and ROCE at 69.75% versus the industry median of 3.89%. These metrics highlight Speciality Medicines Ltd.’s strong financial performance and operational efficiency within the Trading sector.

Peer Comparison

Company	Symbol	Market Cap (Cr)	P/E	P/B	ROE (%)	ROCE (%)
Stratmont Industries Ltd.	STRATMONT	162.72	62.06	5.07	0.53	0.3
Metroglobal Ltd.	METROGLOBL	163.62	9.33	0.42	2.38	3.41
Vaxfab Enterprises Ltd.	VEL	156	41.56	3.89	-0.43	-0.39
Amrapali Industries Ltd.	AMRAPLIN	171.25	14.35	3.93	8.27	18.48
Abate AS Industries Ltd.	ABATEAS	154.14	17.82	0.88	0.98	1.42

Speciality Medicines Ltd. (SPML) has a P/E ratio of 12.14x compared with the displayed peer median of 17.82x. This is a relative valuation comparison, not a buy or sell signal. Its ROE of 76.56% compares with a peer median of 0.98% across the companies shown in the table. ROCE stood at 69.75% versus the displayed peer median of 1.42%, providing a capital-efficiency comparison. Speciality Medicines Ltd. (SPML) has a market capitalisation of Rs 162.54 crore. Among the 5 peers shown, 3 have a larger market capitalisation.

In comparison to its peers, Speciality Medicines Ltd. demonstrates a competitive edge in several key areas. The company’s P/E ratio of 12.14 is lower than that of Stratmont Industries Ltd. (62.06) and Vaxfab Enterprises Ltd. (41.56), indicating a more attractive valuation. However, it is slightly higher than Metroglobal Ltd. (9.33), suggesting room for further analysis.

Speciality Medicines Ltd.’s ROE of 76.56% is notably higher than its peers, with Stratmont Industries Ltd. at 0.53% and Vaxfab Enterprises Ltd. at -0.43%. This strong ROE reflects the company’s ability to generate profits efficiently, setting it apart from competitors in the Trading industry.

Why Investors Are Watching Speciality Medicines Ltd.

Investors are closely monitoring Speciality Medicines Ltd. due to its recent price surge and strong financial metrics. The company’s performance today has positioned it as a top gainer, drawing attention from various market participants.

• Price action: 9.97% rise to Rs 198, exceeding the Micro Cap threshold.
• Technical position: Neutral RSI at 41.21, indicating balanced momentum.
• Fundamental context: Strong ROE of 76.56% and undervalued P/E ratio of 12.14.
• Sector positioning: Competitive edge in the Trading sector with high ROE and ROCE.

As the company continues to demonstrate strong financial performance, investors are likely to keep a close eye on its future developments and market movements.

About Speciality Medicines Ltd.

Speciality Medicines Ltd. operates within the Trading sector, focusing on the distribution and sale of specialty medicines and related products. The company is involved in various segments of the pharmaceutical supply chain, providing essential medicines to healthcare providers and patients across the region.

With a commitment to quality and innovation, Speciality Medicines Ltd. has established itself as a key player in the Trading industry. The company’s diverse product portfolio and strategic partnerships enable it to meet the evolving needs of the healthcare market, driving growth and expansion opportunities.

Track Speciality Medicines Ltd. Share Price on Univest

Use Speciality Medicines Ltd. (SPML) live share-price page, Univest top gainers screener, Univest market blogs to review live stock data, top gainers lists and related market analysis.

Investors can track the live share price of Speciality Medicines Ltd. on Univest, along with key technical indicators, fundamental ratios, and shareholding patterns. Univest provides comprehensive market insights, enabling users to stay informed about the latest developments and trends in the Trading sector.

Frequently Asked Questions

What is the current share price of Speciality Medicines Ltd.?

Ans. The current share price of Speciality Medicines Ltd. is Rs 198, reflecting a 9.97% increase from the previous close of Rs 180.05. The stock moved 9.97% during the session. The intraday range extended from Rs 189.9 to Rs 198.

How much did Speciality Medicines Ltd. share price rise today?

Ans. Speciality Medicines Ltd. share price rose by 9.97% today, reaching Rs 198 from the previous close of Rs 180.05. The stock moved 9.97% during the session. The intraday range extended from Rs 189.9 to Rs 198.

What is the market capitalisation of Speciality Medicines Ltd.?

Ans. The market capitalisation of Speciality Medicines Ltd. is Rs 162.54 crore, categorising it as a Micro Cap company. The company operates in the Trading sector. Its P/E ratio is 12.14x.

What is the P/E ratio of Speciality Medicines Ltd.?

Ans. The P/E ratio of Speciality Medicines Ltd. is 12.14, which is below the industry median of 14.93, indicating potential undervaluation. The company trades at a P/E ratio of 12.14x. Its P/B ratio is 2.22x.

What is the ROE of Speciality Medicines Ltd.?

Ans. The ROE of Speciality Medicines Ltd. is 76.56%, significantly higher than the industry median of 1.97%, highlighting strong profitability. ROE stands at 76.56%. ROCE stands at 69.75%. The relevant peer median ROE is 1.97%.

How does Speciality Medicines Ltd. compare to its peers?

Ans. Speciality Medicines Ltd. has a lower P/E ratio and higher ROE compared to peers like Stratmont Industries Ltd. and Vaxfab Enterprises Ltd. Comparable listed companies include Stratmont Industries Ltd., Metroglobal Ltd., Vaxfab Enterprises Ltd.

What sector does Speciality Medicines Ltd. operate in?

Ans. Speciality Medicines Ltd. operates in the Trading sector, focusing on the distribution and sale of specialty medicines. The stock belongs to the Trading sector. Its industry classification is Trading. 435 comparable companies were included in the benchmark.